Choose other agents are suggested as choice agents determined by administration concerns and/or adverse influence profile.  Zidovudine coupled with lamivudine is the alternative NRTI backbone but is related to much more hematologic toxicity. Lopinavir/ritonavir is another PI agent with founded security but displays better gastrointestinal intolera